The QualityStocks Daily Friday, June 8th, 2018

Today's Top 3 Investment Newsletters


QualityStocks (RGUS) +40.65%

MarketBeat (CTDH) +33.33%

The QualityStocks Daily Stock List

Q BioMed, Inc. (QBIO)

Stock News Now, StockPicksNYC, and SeeThruEquityResearch reported earlier on Q BioMed, Inc. (QBIO), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a biomedical acceleration and development company listed on the OTC Markets Group’s OTCQB. Its commitment is on licensing and acquiring biomedical assets across the healthcare spectrum. The Company previously went by the name ISMO Tech Solutions, Inc. It changed its name to Q BioMed, Inc. in July 2015. Q BioMed has its corporate headquarters in New York, New York.

The Company’s dedication is to provide these target assets the strategic resources, developmental support, and expansion capital they need to ensure they meet their developmental potential, enabling them to provide products to patients in need. Q BioMed’s mission is to license and acquire pioneering life sciences assets from academia or small private companies.

Q BioMed is centering on clinical stage and unique products where the technical, regulatory, and commercial risks have been reduced or major valuation inflections are pending. The Company has manifold assets across a wide array of healthcare related products, companies, and sectors. These assets will undergo development to provide returns through organic growth or out-licensing, sale, or be spun out into new public companies.

In addition, Q BioMed is developing an innovative molecule delivered in an easy-to-administer eye drop designed to repair the normal flow of fluid in the eye resulting in the lessening of IOP (Intraocular Pressure) - one of the primary causes of glaucoma.

This platform is unique and first-in-class. Q BioMed, together with its partner, Mannin Research, Inc, is the only company targeting this mechanism of action.

Q Biomed has entered into a final license agreement with The Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB). With the agreement, Q BioMed has the worldwide exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.

The Company has started production of Strontium-89 Chloride. This is a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain. AB-Rated Strontium Chloride Sr89 Injection USP (Sr89) can be used in combination with, or to reduce the need for opiate based drugs, and also in combination with cancer therapeutic drugs.

Last week, Q BioMed announced an exclusive option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q BioMed will evaluate the feasibility and usability of GDF-15, a novel biomarker for monitoring glaucoma, as a companion diagnostic to the MAN-01 small molecule now undergoing optimization for the topical treatment of glaucoma.

Yesterday, Q BioMed announced that it welcomes Dr. Rick Panicucci as an independent member on the Company’s Board of Directors. Dr. Panicucci is the Vice President of Pharmaceutical Development at STA Pharmaceutical Co. Ltd. (A WuXi AppTec Company). He is responsible for providing scientific leadership in the areas of Developability, Formulation Development and GMP Manufacturing. Dr. Panicucci has been providing formulation and development support to Mannin Research on Man01, Q BioMed’s glaucoma drug candidate.

Q BioMed, Inc. (QBIO), closed Friday's trading session at $3.57, up 2.00%, on 74,448 volume with 165 trades. The average volume for the last 60 days is 88,247 and the stock's 52-week low/high is $2.73/$5.90.


AltiGen Communications, Inc. (ATGN)

OTC Markets, Zacks, MarketWatch, and Marketbeat reported on AltiGen Communications, Inc. (ATGN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AltiGen Communications, Inc. is a provider of Hosted Skype for Business and Contact Center solutions. The Company is a leading Microsoft Cloud Solutions provider. It delivers fully managed Unified Communications services, combining Hosted Skype for Business, Advanced Cloud PBX, and Innovative Cloud Contact Center applications with seamless integration to Office 365. OTCQB-listed, AltiGen Communications is based in San Jose, California.

The design of AltiGen’s solutions is for high reliability, user-friendliness, and seamless integration to Microsoft infrastructure technologies. The Company’s solutions are built on a scalable, open standards platform.

AltiGen Communications’ Cloud Unified Communications solution significantly simplifies deployment and management. This is while enabling SMBs and enterprises to substantially reduce costs and lower total cost of ownership. The Company’s all-software solution provides businesses the flexibility to deploy on-premises, in the Cloud, or in a hybrid environment.

AltiGen’s unique and feature rich Cloud PBX and Multi-Channel Contact Center solutions natively integrate with Skype for Business and Office 365. This is to deliver business-critical functionalities required by SMBs (Small and Midsize Businesses) and enterprises.

The Company’s MaxUC is an innovative new Unified Communications solution. It combines AltiGen’s MaxCS IP PBX with Microsoft’s Skype for Business. In addition, AltiGen has its MaxCS SIP Trunk. The SIP Trunk Service is an enterprise grade VoIP service optimized for AltiGen Communications solutions.

Furthermore, AltiGen has its Enterprise Cloud PBX. This is a total Cloud-based enterprise-wide PBX and Contact Center solution for Office 365, based on the Company’s Hosted Skype for Business, integrated with its MaxACD advanced communications application set.

AltiGen also has its MaxACD Cloud. MaxACD enhances Skype for Business and Office 365 with Cloud-based Automated Multimedia Routing and Queuing capabilities to address the Enterprise “Line of Business” requirements for Internal or External customer requests.

This past April, AltiGen Communications announced its financial results for Q2 ended March 31, 2018. Financial highlights for the quarter include Revenue of $2.5 million. This represents a 21 percent increase over the year-ago Q2. Net Income was $383,000 GAAP (Generally Accepted Accounting Principles), and $390,000 non-GAAP. For the six months, Revenue was $4.8 million. This represents a 15 percent increase over the previous year. Net Income was $721,000 GAAP, and $733,000 non-GAAP.

AltiGen Communications, Inc. (ATGN), closed Friday's trading session at $0.5592, even for the day. The average volume for the last 60 days is 18,479 and the stock's 52-week low/high is $0.201/$0.64.


MariMed, Inc. (MRMD)

Investors Hub, OTC Markets, and Daily Marijuana Observer reported on MariMed, Inc. (MRMD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

MariMed, Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation and production centers and dispensaries. The Company provides turnkey solutions to cannabis cultivators, producers, as well as dispensaries. It specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales. MariMed is headquartered in Newton, Massachusetts.

The Company is concentrating exclusively on serving the fast growing $7 billion legal cannabis industry. Last year it announced the purchase of a 137,500 sq. ft. industrial building on 17 acres at 167 John Vertente Blvd., in the New Bedford, Massachusetts industrial park. MariMed will develop around 70,000 sq. ft. into a full service, state-of-the-art medical cannabis cultivation and production facility. This has been leased to ARL Healthcare, Inc. (ARL), a Massachusetts not for profit corporation.

MariMed is working to create precision dosed products to treat specific conditions. The Company’s team has developed state-of-the-art and regulatory compliant facilities in numerous states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.

MariMed provides a comprehensive range of consulting services in the medical cannabis industry. It uses a systematic approach, from the permit and application process, to on-time operational readiness.  Cannabis experts, the Company specializes in supporting the development of high quality state-licensed, medical cannabis dispensaries and cultivation facilities.

The Company’s services include application assistance, real estate and safe access, build-out and continuing consultation, business acceleration solutions, and physician and patient outreach. MariMed Advisors, Inc. has a portfolio of high-quality branded products, product development plans, product packaging, and product licensing opportunities.

MariMed has expanded the licensing and distribution of its branded cannabis product line into Maryland. The products are being produced by Kind Therapeutics USA at its 100,000 sq. ft. state licensed medical marijuana production facility in Hagerstown, Maryland. Kind Therapeutics USA is distributing these products to about 35 dispensaries throughout Maryland.

Today, MariMed announced that three executives will share their expertise on successfully securing real estate for cannabis businesses at the New England Real Estate Journal’s (NEREJ) 2018 Cannabis & Commercial Real Estate (CRE Summit). Company CEO Mr. Robert Fireman, CFO Mr. Jon Levine and COO Mr. Tim Shaw will provide real experiences gained from developing marijuana cultivation, production and dispensary facilities in six states and decades of collective executive experience in commercial real estate at The Summit’s two panels.

The Cannabis & CRE Summit is 9:30 a.m. to noon, Wednesday, June 13, 2018 at the Boston Convention and Exhibition Center, 415 Summer St., Boston.

MariMed, Inc. (MRMD), closed Friday's trading session at $2.10, up 14.75%, on 769,362 volume with 700 trades. The average volume for the last 60 days is 141,872 and the stock's 52-week low/high is $0.201/$1.98.


Solis Tek, Inc. (SLTK)

Zacks, Trading View, and MarketWatch reported on Solis Tek, Inc. (SLTK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Solis Tek, Inc. is a vertically integrated technology innovator, developer, manufacturer, and distributor. The Company’s focus is on bringing products and solutions to commercial cannabis growers in legal markets across the U.S. Its emphasis is on the research, design, development, and manufacturing of advanced and efficient lighting products. Solis Tek’s customers include retail stores, distributors, and and commercial growers in the U.S. and around the world. Solis Tek is based in Carson, California.

The Company’s technology covers Ignition Control; SenseSmart™, and the industry’s lowest output THD (Total Harmonic Distortion) percent. Solis Tek states that its ballasts offer the industry's only true Ignition Control staggered ignition technology. Its sequential lamp ignition technology will ignite lamps one at a time based on load stability.

Solis Tek’s SenseSmart™ will check for eight different factors before attempting to power the lamp. The intention of this is increased user safety. SenseSmart™ checks for open output; high/low temperatures; ignition failure; thermal; end of lamp life; overflow current; over/low voltage; and short circuit.

Solis Tek provides a comprehensive line of lighting equipment and accessories to help its customers realize higher yields and maximize quality. The Company’s product categories include complete systems; digital ballasts, DE Lamps; SE Lamps; CMH Lamps; Reflectors; and accessories.

The Company has its Nutrient Line. This Line uses natural ingredients to help growers increase yield, lower costs, and ultimately grow healthier plants. This is an element of Solis Tek’s overall strategy to provide a wide-ranging group of products and services targeted at the commercial cannabis industry.

Terpenez™ is the first product in the Nutrient Line. This product is an organically derived, commercial grade essential oil intensifier blended in California. The design of it is to naturally increase the terpene profile of the cannabis plant and enhance the aromatic experience associated with gardening.

Terpenez™ identifies the plant's terpene profile. It uses natural ingredients to increase the terpene levels, accordingly enhancing the plant's innate characteristics.

Solis Tek offers its lighting controller, which enables commercial growers to harness more control of their gardens lighting environment. The Solis Tek Controller works with up to 300 lights at once. It allows growers to manage multiple lighting cycles, located in different rooms/locations.

In January, Solis Tek commented on the California Bureau of Medical Cannabis Regulation's new regulations announced on January 1, 2018, banning the use of a long list of pesticides in cannabis cultivation for medical and adult-use industries. This list represents the strictest in the nation to protect users from ingesting cannabis with harsh chemicals, heavy metals, as well as other properties.

Mr. Dennis G. Forchic, Solis Tek’s Chief Executive Officer, said, "Solis Tek applauds the California Bureau of Medical Cannabis Regulation and encourages other governing bodies in states with adult- and medical-use laws in place to take the same responsible look at how flower is being cultivated with an eye toward protecting consumers."

Solis Tek, Inc. (SLTK), closed Friday's trading session at $0.9201, up 2.23%, on 49,269 volume with 50 trades. The average volume for the last 60 days is 72,167 and the stock's 52-week low/high is $0.845/$2.64.


Giggles N' Hugs, Inc. (GIGL)

SeriousTraders,, Investor's Insight, RedChip, OTCJournal, StocksToBuyNow, SmallCap Network, SmallCapVoice, and Money and Markets reported earlier on Giggles N' Hugs, Inc. (GIGL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Giggles N' Hugs, Inc. is the owner and operator of family-friendly restaurants. These restaurants bring together high-end, organic food with active, leading-edge play and entertainment for children. The Company features high-quality menus made from fresh and local foods. Established in 2010, Giggles N' Hugs is based in Glendale, California.

Each Giggles N' Hugs location offers an upscale, family-friendly atmosphere with a dedicated play area for children 10 and younger. In addition, the Company features nightly entertainment. This includes magic shows, concerts, puppet shows, and face painting, as well as party packages for families.

Membership at Giggles N' Hugs comes with benefits. These include first access to its special kids’ events, monthly deals, and unlimited visits for the whole family.

The Company was listed best family & kid-friendly restaurants by CitySearch and GoCityKids. Giggles N’ Hugs has locations in Topanga and Glendale, California.

Giggles N’ Hugs was also voted the #1 birthday party place in Los Angeles by Nickelodeon. Moreover, it was voted "Best Pizza in Los Angeles" by Nickelodeon.

In May of 2017, Giggles N’ Hugs announced that it signed a non-binding Letter of Intent (LOI) with City Scape trading (franchisee), a Bahrain-based hospitality company, to open up to two Giggles N’ Hugs franchise locations in Bahrain with more locations to come if successful. With this master license agreement, Giggles N’ Hugs will receive up-front development fees for each location, and also an ongoing royalty based on a percentage of monthly gross sales.

Giggles N’ Hugs has engaged Pacific Shore Ventures to explore potential synergistic acquisition opportunities. PacificShore is a global specialty finance and Mergers & Acquisitions (M&A) firm.

Giggles N' Hugs is targeting companies that are cash flow positive and have minimum annual revenue of $5 million or more. PacificShore will work to identify and create target company profiles, introduce, initiate negotiations, and ultimately facilitate the closing of such potential companies and introduce traditional banking relationships for Giggles N' Hugs to finance the acquisitions.

Last month, Giggles N’ Hugs announced that it now accepts Bitcoin as a payment option for customers. Via BitPay, Giggles N’ Hugs customers can use their phones or email to complete payments. By way of BitPay, Giggles N Hugs receives direct bank deposits for a flat 1 percent settlement charge.

Giggles N' Hugs, Inc. (GIGL), closed Friday's trading session at $0.014, up 4.48%, on 91,300 volume with 11 trades. The average volume for the last 60 days is 420,406 and the stock's 52-week low/high is $0.0127/$0.139.


Propanc Biopharma, Inc. (PPCB)

InvestorsHub and Investing News reported on Propanc Biopharma, Inc. (PPCB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Propanc Biopharma, Inc. is a clinical stage Biopharmaceutical Company listed on the OTCQB. It focuses on the development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian, and colorectal cancers. The Company has developed a formulation of anti-cancer compounds that exert numerous effects designed to control or prevent tumors from recurring and spreading throughout the body. Propanc Biopharma has its head office in Australia.

The Company is developing a long-term therapy founded on a pancreatic proenzyme formulation to prevent tumour recurrence and metastasis. Its lead product is PRP. This is a novel, patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is a solution for once daily intravenous administration of a combination of two pancreatic proenzymes, trypsinogen and chymotrypsinogen, for the treatment of pancreatic cancer.

Propanc Biopharma has received Orphan Drug Designation (ODD) from the Food and Drug Administration (FDA) for the use of PRP. The approved indication is one of the most lethal malignancies with a median survival of 6 months and a 5-year survival rate of less than 5 percent.

Propanc (after extensive laboratory research and a limited amount of human testing) has evidence that PRP lessen cancer cell growth through promotion of cell differentiation; enhances cell adhesion, and may suppress metastasis progression; and has no serious side effects and improves patient survival.

Development progress for PRP includes successful completion of a GLP-compliant, 28-day repeat-dose toxicity study with no toxicological findings after administration. This indicates a broad safety margin. It provides sufficient data to support a safe starting dose for First-In-Human studies.

Additionally, a manufacturing process capable of purifying and stabilizing two active drug substances of the PRP formulation, trypsinogen and chymotrypsinogen were successfully developed. Furthermore, the FDA granted Orphan Drug Designation status to PRP for the treatment of pancreatic cancer.

This past March, Propanc Biopharma announced the successful reproduction run of the manufacturing process for its two drug substances trypsinogen and chymotrypsinogen. The successful reproduction run demonstrates scalability of the Company's proprietary manufacturing process to enable routine production of the two active substances for Propanc’s lead product candidate, PRP. The process was developed in collaboration with a European Contract Manufacturing Organization (CMO) experienced in the production of biopharmaceuticals.

Recently, Propanc Biopharma announced the completion of a scientific advice meeting with the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, pertaining to the investigational medicinal product (IMP) manufacturing program for PRP. Several topics were raised and clarified concerning the preparation of a clinical trial application (CTA) for a First-In-Human study in the UK.

Important topics included the definition of starting material under Good Manufacturing Practice (GMP) principles and certain tests to be conducted as part of the continuing quality assurance and control requirements for manufacture of a biological product for human use.

Propanc Biopharma, Inc. (PPCB), closed Friday's trading session at $2.10, down 1.43%, on 301,767 volume with 38 trades. The average volume for the last 60 days is 575,939 and the stock's 52-week low/high is $0.04/$1.40.


Optex Systems Holdings, Inc. (OPXS)

StockRockandRoll, Epic Stock Picks, Wolf of Penny Stocks, DSR News, PHUB News, William Velmer, Stock Beast, DamnGoodPennyStock, Penny Stock Newsletter, Stock Commander, MicroCapDaily, OTCMagic, Damn Good Penny Picks, Penny Picks,, PREPUMP STOCKS and S.A. Advisory reported on Optex Systems Holdings, Inc. (OPXS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Optex Systems Holdings, Inc. is a leading manufacturer of optical sighting systems and assemblies, mainly for Department of Defense (DoD) applications. In addition, the Company manufactures and delivers multiple periscope configurations, rifle and surveillance sights, and night vision optical assemblies. It delivers its products directly to the military services and to prime contractors. OTCQB-listed, Optex Systems Holdings is has its corporate headquarters in Richardson, Texas.

Optex Systems, Inc. is a wholly-owned subsidiary of Optex Systems Holdings. In November of 2014, Optex Systems Holdings reported the completion of the acquisition of the Applied Optics Center (AOC) Division of Warrior Systems Sector with the Electronics Systems Business Segment of L-3 Communications Corp.

Optex Systems Holdings’ products are installed on diverse kinds of U.S. military land vehicles. These include the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles. Additionally, the Company’s products have been selected for installation on the Stryker family of vehicles.

Optex Systems manufactures the US Navy 20x 120mm Ship Binoculars and also brings creative technology to vehicular mounted sighting systems. Its dismounted sighting systems work on weapon sights, night vision goggles, and any other sighting requirements outside of ships and land vehicles. Moreover, Optex Systems can meet commercial (non-military) requirements.

This past October, Optex Systems, Inc., the wholly owned subsidiary of Optex Systems Holdings, announced it was awarded a $1 Million contract in two separate orders through Defense Logistics Association (DLA) in support of the Abrams Main Battle Tank platform.

Regarding Fiscal Year 2017 financial highlights, Optex Systems Holdings’ backlog as of October 1, 2017 was $15.7 million versus a backlog of $12.0 million as of October 2, 2016. This represents an increase of $3.7 million or 30.8 percent.

During the twelve months ending October 1, 2017, Optex Systems booked $22.3 million, a 26.7 percent increase, versus new orders of $17.6 million booked during the previous year.

The Company’s consolidated revenue for the twelve month period ending October 1, 2017 was $18.5 million versus the previous year nine months period ending October 2, 2016 revenue of $17.3 million.

During the period ending October 1, 2017, Optex Systems Holdings recorded operating income of $0.2 million versus an operating loss of ($0.9) million during the period ending October 2, 2016. During the year ended October 1, 2017, the Company recorded a net loss applicable to common shareholders of ($0.3) million versus a net loss applicable to common shareholders of ($1.4) million during the year ended October 2, 2016.

Optex Systems Holdings, Inc. (OPXS), closed Friday's trading session at $1.09, up 0.93%, on 10,590 volume with 6 trades. The average volume for the last 60 days is 28,312 and the stock's 52-week low/high is $0.7608/$1.30.


Aspen Group, Inc. (ASPU)

Greenbackers, TaglichBrothers, TheMicrocapNews, Stock News Now, and RedChip reported previously on Aspen Group, Inc. (ASPU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aspen Group, Inc. is a for-profit post-secondary education company. Aspen Group owns two accredited universities. These are Aspen University and United States University. The mission of Aspen University is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education to achieve sustainable economic and social benefits for themselves and their families. Aspen Group is based in New York, New York. The Company lists on the OTCQB.

Aspen University’s commitment is to provide the highest quality education experiences taught by top-tier faculty. Of note is that more than 50 percent of Aspen University’s faculty hold doctoral degrees.

Degrees offered by Aspen University include Associates, Bachelor’s, Master’s, Doctoral, and Certificates. Aspen University has its School of Professional Studies, School of Nursing, School of Education, School of Management, School of Information Technology, and College of Arts and Sciences.

United States University began its institutional history in 1997 as InterAmerican College in National City, California. In 2010, the school was renamed United States University. United States University has its campus in the heart of San Diego, California.

United States University is regionally accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges. United States University offers Bachelor and Master level degree programs in nursing, education, health science, and also business & management.

Aspen Group announced in July 2017 Aspen University’s launch of the Doctor of Nursing Practice (DNP) in Leadership online degree program. The design of the DNP degree is to be a practice-centered program, which combines a scholarly approach to the discipline of nursing. The program prepares advanced practice nurses and educators to lead their organizations and the next generation of nurses.

Last month, Aspen Group announced that United States University (USU) appointed Dr. Dianna Scherlin, DNP, MS, BS, RN as Dean of its growing College of Nursing. Dr. Scherlin has amassed a record of successful educational administration and leadership built upon a strong foundation of experience and teaching. Her background consists of leadership and senior academic management in higher education at the level of Dean, Provost, and corporate and national Director.

Last week, Aspen Group announced the appointment of Dr. Anne McNamara, Ph.D., RN, to Chief Nursing Officer at Aspen University.  Dr. McNamara’s primary responsibility will be to supervise the expansion of Aspen University’s BSN Pre-Licensure program across the nation. Dr. McNamara is a nationally known nursing leader with over four decades of experience.

Aspen Group, Inc. (ASPU), closed Friday's trading session at $7.20, down 1.37%, on 79,882 volume with 394 trades. The average volume for the last 60 days is 42,253 and the stock's 52-week low/high is $5.35/$9.61.


Bannerman Resources Limited (BNNLF)

Penny Stock Tweets, Speculating Stocks, Research and Markets, Streetwise Reports, Stockhouse, MarketWatch, Morningstar, Northern Miner, CapitalCube, WalletInvestor, HotStocked, 4-Traders, MoneyHub, The Stock Market Watch, Barchart, Ventureline, and Wallmine reported on Bannerman Resources Limited (BNNLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bannerman Resources Limited is an exploration and development company with a 95 percent interest in the Etango Uranium Project in Namibia. The Company Bannerman is a member of the Namibian Uranium Association, Namibian Chamber of Mines and the Australia-Africa Minerals % Energy Group (AAMEG). Bannerman Resources has its corporate headquarters in Subiaco
Western Australia.

The Etango Uranium Project is one of the world’s largest undeveloped uranium projects. The Project is one of the few uranium projects globally with a completed Definitive Feasibility Study (DFS) and environmental permitting. It will be a top 10 producer upon development.

The Etango Uranium Project is considered by the Company to be a low technical and environmental risk project, with conventional open pit mining and sulphuric acid heap leaching at 20 million tonnes each year. The Etango license area is roughly 500 square kms.

The Project is located on the flat Namib Desert sands, about 38 kilometers (by road) east of the coastal town of Swakopmund. The Project is well located for external infrastructure requirements.

Recently, Bannerman Resources reported on a productive March quarter during which the Etango Project was progressed through successful completion of the Membrane Study.

Mr. Brandon Munro, Chief Executive officer of Bannerman Resources, said, “During the March quarter Bannerman continued to sensibly and efficiently progress the Etango uranium project. The Membrane Study was completed, confirming at a definitive level that established nano-filtration technology could be applied to reduce reagent costs and generate potential capital savings.  This study was completed largely using internal resources and sunk costs, in particular the Etango Heap Leach Demonstration Plant, resulting in an outstanding return on the modest external expenditure.”

Today, Bannerman Resources announced that it received commitments to raise A$8 million gross proceeds via the placement of 173,913,043 new Bannerman shares at an issue price of A$0.046 per share. Funds raised from the Placement will be used to further optimize opportunities at the Etango Project targeting reduced operating and capital cost estimates. Funds will also be used to progress the current Definitive Feasibility Study (DFS) Update, continue product marketing, and for general working capital and corporate purposes. This includes financing and offtake initiatives.  

Bannerman Resources Limited (BNNLF), closed Friday's trading session at $0.05, up 11.11%, on 615,404 volume with 4 trades. The average volume for the last 60 days is 30,932 and the stock's 52-week low/high is $0.0201/$0.055.


REGI U.S., Inc. (RGUS)

MarketWatch, Marketwired, and Stockhouse reported earlier on REGI U.S., Inc. (RGUS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

REGI U.S., Inc., by way of its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization numerous improved axial vane type rotary devices employing its Patented RadMax™ Rotary Technology. REGI U.S. is headquartered in Spokane, Washington.

The RadMax™ Rotary Technology allows for pioneering designs of lightweight and high efficiency engines, compressors, pumps, and other devices. One current prototype is The RadMax™ engine. It has only two unique moving parts, the vanes (up to 12) and the rotor, in comparison to the 40 moving parts in a basic four-cylinder piston engine.

The innovative design makes it possible to produce up to 24 continuous power impulses per one rotation, which is vibration-free and very quiet. Furthermore, the RadMax™ engine has several capabilities allowing it to operate on fuels such as gasoline, natural gas, hydrogen, propane, and diesel.

In essence, REGI U.S.’s goal is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.

Last month, The Board of Directors, REGI U.S. and its wholly owned subsidiary, RadMax Technologies announced continued progress in the development of the RadMax prototype, proof-of-concept gas expander with integrated electricity generation capability. Three iterations of the expander design have developed during the past several months resulting from continual materials, sealing methods and individual component testing.

Design improvements include low friction vane and rotating seal designs that outperformed expectations. The Company stated that encouraging results from testing have led to the filing of three new provisional patents with a number of others still undergoing consideration.

REGI U.S., Inc. (RGUS), closed Friday's trading session at $0.10, up 40.65%, on 57,500 volume with 8 trades. The average volume for the last 60 days is 13,113 and the stock's 52-week low/high is $0.0515/$0.30.


Artemis Therapeutics, Inc. (ATMS)

Zacks, Stockhouse, InvestorsHub,, OTC Markets and Simply Wall St reported on Artemis Therapeutics, Inc. (ATMS), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Artemis Therapeutics, Inc. focuses on the development of new therapies for the treatment and prevention of severe and life-threatening infectious diseases. The Company’s lead product candidate is Artemisone. This is an innovative, synthetic artemisinin derivative with potent anti-viral and anti-parasitic properties.  A clinical-stage biopharmaceutical company, Artemis Therapeutics is headquartered in New York, New York.

Artemisone is a best-in-class artemisinin. It has been studied in a Phase 2 clinical trial for the treatment of malaria (p. falciparum). Currently, Artemisone is undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV). This includes transplant CMV and congenital CMV.

Artemisinin and its derivatives, including artesunate, artemether, arteeter and dihydro-atemisinin (DHA), have for many years been the basis of treatment of uncomplicated p. falciparum malaria. Phase II clinical data has shown Artemisone to be an efficacious treatment for p. falciparum malaria infection when dosed over a 2-day or 3-day course, similar to or shorter than other available malaria treatments.

Artemis Therapeutics has licensed pre-clinical data from Hadasit Medical Research Services and Development Ltd. in HCMV and clinical data from Hong Kong University of Science and Technology R and D Corporation Limited (RDC) in the treatment of Malaria.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Artemisone for the treatment of malaria. The Company is now qualified to receive considerable benefits via its orphan drug development program. This includes more frequent FDA interactions, protocol assistance, and tax credits for clinical research expenses.

This past April, Artemis Therapeutics announced the decision by the Japanese Patent Office to allow the patent entitled "Methods and Compositions for Treating Viral Infections". The patent covers certain compositions, including Artemisone, Artemis’ lead product candidate, for use in treating or suppressing herpes virus infection and replication. This patent will provide intellectual property (IP) protection for the Artemisone program in Japan. The expectation is that it will expire no earlier than April, 2033.

Yesterday, Artemis Therapeutics announced that new data on its lead product candidate Artemisone shows it is a potent inhibitor of human cytomegalovirus (HCMV) replication in preclinical assays.  Artemis’ Chief Medical Officer, Dana Wolf, M.D., Ph.D., will share the data in an oral presentation on June 9, 2018 at the American Society of Microbiology annual meeting in Atlanta (ASM Microbe 2018), as part of Session 305, CMV Resistance: Limited Options but a Promising Future.

Artemis Therapeutics, Inc. (ATMS), closed Friday's trading session at $1.15, down 0.01%, on 200 volume with 2 trades. The average volume for the last 60 days is 734 and the stock's 52-week low/high is $0.6501/$1.70.


Bion Environmental Technologies, Inc. (BNET)

OTC Stock Review, Wall Street Resources, TopPennyStockMovers, SECFilings News, and Stock Guru reported previously on Bion Environmental Technologies, Inc. (BNET), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bion Environmental Technologies, Inc. is a developer of advanced livestock waste treatment and resource recovery technology. The Company’s patented, next-generation technology provides verified comprehensive treatment of animal waste from large-scale livestock production facilities. Bion Environmental Technologies has its corporate office in Crestone, Colorado, and its administrative office in Old Bethpage, New York.

The Company’s technology platform is a modular system. It can be configured in an array of ways, depending on farm- and region-specific requirements. The system creates new revenue sources and opportunities for the producer.

Bion’s technology platform achieves considerable reductions in environmental impacts. This includes nutrients (nitrogen and phosphorus), ammonia, greenhouse and other gases, and pathogens in the waste stream. This is while improving resource and operational efficiencies via the recovery of valuable byproducts.

The Company’s 2nd generation (2G) Comprehensive Environmental Management System removes up to 95 percent of the nutrients from the livestock waste effluent. It significantly reduces air emissions. This includes ammonia (as great as 90 percent or more), greenhouse gases, hydrogen sulfide, VOC’s, and others. The system extracts renewable energy from the waste stream in the form of cellulosic biomass.

Bion’s treatment solutions are a combination of biological, mechanical, and thermal processes. These are proven in commercial operations. They have been accepted by the EPA (Environmental Protection Agency), the USDA (United States Department of Agriculture), and other regulatory agencies.

Last month, Bion Environmental Technologies gave an update on its third-generation technology.

Mr. Dominic Bassani, the Company’s Chief Executive Officer, stated, "Independent testing related to Bion's proprietary (patent-pending) ammonia recovery system confirms progress in significantly reducing both capital and operating costs for our third-generation (3G) technology, while continuing to conform to OMRI [Organic Materials Review Institute] standards. We are preparing our initial OMRI application, which will begin the process to certify our produced liquid ammonia for use in organic production; we expect to file this initial application soon."

Bion Environmental Technologies, Inc. (BNET), closed Friday's trading session at $0.56, up 3.70%, on 504 volume with 1 trade. The average volume for the last 60 days is 8,599 and the stock's 52-week low/high is $0.42/$0.98.


The QualityStocks Company Corner

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

ValuEngine, a stock valuation and forecasting service, recently provided an update regarding global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE). To view the full article, visit:

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.40, up 14.20%, on 589,519 volume with 2,035 trades. The average volume for the last 60 days is 462,993 and the stock's 52-week low/high is $2.556/$33.51.

Recent News


Aftermaster, Inc. (OTCQB: AFTM)

The QualityStocks Daily Newsletter would like to spotlight Aftermaster, Inc. (AFTM).

Aftermaster, Inc.’s (OTCQB: AFTM) technology provides capability to improve audio from virtually any source, enabling seemingly magical improvements by beginners in home device sound mastery. To view the full article, visit:

Aftermaster, Inc. (OTCQB: AFTM), with offices in Scottsdale, Arizona, and Hollywood California, is an award-winning, leading-edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. The company also operates world-class mastering and recording studios located in the heart of Hollywood, California, in the famous Crossroads of the World complex along Sunset Boulevard.

Aftermaster and its subsidiaries are engaged in the development and commercialization of proprietary (patents issued and pending), leading-edge audio and video technologies for professional and consumer use including the award-winning AfterMaster® audio technology, ProMaster™ and Aftermaster Pro™. Aftermaster is unique in the audio world because its team has produced, engineered and mastered more hit records than any audio company in the world. The Aftermaster team knows what sounds right and the Company holds a unique position in the world of audio technology.

The Company’s underlying technology, Aftermaster audio, delivers an audio experience unrivaled by any audio company. It brings an unprecedented new quality level to consumer audio by offering unparalleled clarity, depth, fullness and a significant volume increase to audio recordings without distortion or altering the original recording. Its versatility and smart processing characteristics make it effective across a broad range of applications from consumer electronics to industrial applications.

The Company also operates Aftermaster Recording and Mastering Studios which include the renovated production facilities of legendary director Alfred Hitchcock and the iconic recording studios of Crosby, Stills and Nash.

Aftermaster Labs maintains five primary business units: Aftermaster proprietary semiconductor chip and software for OEM licensing, proprietary consumer electronics, professional music mastering, online mastering, recording and mixing at its Aftermaster Recording and Master Studios, and Audio Consulting services. The Aftermaster semiconductor chip and software is used for embedding in consumer products, Aftermaster-developed and branded consumer and professional electronic products, ProMaster on-line music mastering for independent music artists and in-studio professional music mastering services.

Aftermaster has increasingly attracted interest from some of the music industry’s leading audio companies. A newly expanded partnership with TuneCore, the leading digital music distribution and publishing administration provider, gives TuneCore members access to Promaster through its instant mastering service which offers audio mastering of unparalleled quality at the click of a button. The Company also recently entered into a licensing agreement with Muzik headphones for use of its Aftermaster chip in their new headphone line.

The company’s first groundbreaking consumer product – the Aftermaster Pro – is designed to solve the universally widespread problem of poor, variable audio levels of television audio. Aftermaster Pro, which is smaller than an iPhone, masters and remasters inconsistent TV audio in real-time, creating an audio experience that offers clear, full-bodied depths of sound and most importantly, overall balanced audio. The Aftermaster Pro virtually eliminates the need to adjust TV volume to hear dialogue or to reduce the level of loud special effects. The Aftermaster Pro sells for $179 and is enjoying strong growth in sales to over 65 countries.

With the Company’s Promaster, state-of-the-art proprietary algorithms, artists receive four CD quality mastered versions of their track including “Powerful,” “Radio Ready,” “Bass Enhanced,” and “Vocal Enhanced.”  TuneCore artists have access to exclusive pricing on the Promaster pay-as-you-go instant mastering, as well as unlimited monthly and annual subscriptions. Aftermaster also holds a license agreement with headphone manufacturer, Muzik, Inc., for the use of Aftermaster’s patented audio remastering and audio enhancement technology.

Aftermaster won three Envisioneering Innovation and Design Awards at the 2016 Consumer Electronics Show in Las Vegas for both its Aftermaster TV device and its BelaSigna 300 processor semiconductor chip created through a partnership with ON Semiconductor. Aftermaster was also named an honoree for its ProMaster audio technology.

Aftermaster Audio Labs is led by a group of world-class audio engineers and music industry veterans who have been involved with the development and implementation of countless successful proprietary audio technologies and products.

The Team

Aftermaster co-founder and CEO Larry Ryckman is an award-winning entertainment and technology executive with over 25 years of achievements in the music and entertainment industries.

Shelly Yakus, co-founder and chief engineer at Aftermaster Audio Labs, is a renowned music producer, audio engineer/mixer and is widely considered the best engineer and mixer in the music industry.

Justin Timberlake, a Grammy and Emmy award-winning singer/songwriter/producer and actor, is a co-owner of Aftermaster Audio Labs, Inc. Timberlake is widely considered to be one of pop culture’s most influential entertainers in the world.

Peter Doell is one of the best-known mastering engineers in the world with over 35 years of experience mastering and engineering hundreds of chart-topping records, film scores and TV spots. Rodney Jerkins is an 8-time Grammy Award winning music producer/songwriter and considered to be one of the most influential and successful producers in the music industry.

Paul Wolff is a senior engineer and product development consultant at Aftermaster Audio Labs. Wolff has been involved in the professional music and audio industries as an audio engineer and product designer and manufacturer of professional audio products for more than 35 years.

Thousands of hours of testing millions of songs and audio sources of all types have been processed using Aftermaster’s award-winning technology and the results speak for themselves with platinum records, numerous strategic partnerships, and overwhelming industry support.

Aftermaster, Inc. (AFTM), closed the day's trading session at $0.061, up 10.91%, on 321,000 volume with 17 trades. The average volume for the last 60 days is 354,572 and the stock's 52-week low/high is $0.035/$0.25.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) was featured on this week on MoneyTV with Donald Baillargeon. The television program can also be viewed online at Also today, CannabisNewsWire released a report on the company detailing how CIIX recently announced that it has entered into a licensing partnership with The Bad Crypto Podcast.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.4999, up 6.36%, on 34,289 volume with 35 trades. The average volume for the last 60 days is 58,535 and the stock's 52-week low/high is $0.40/$1.58.

Recent News


Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions Inc. (OTC: REFG) has acquired 40 acres of land to grow hemp in Utah and plans to seek a state license under its recently passed law H.B. 302. The license will enable the company to grow industrial hemp as part of the state’s Department of Agriculture and Food licensing program (

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0475, up 2.15%, on 429,627 volume with 70 trades. The average volume for the last 60 days is 583,444 and the stock's 52-week low/high is $0.0161/$0.092.

Recent News


Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Software development and mobile solutions company Consorteum Holdings (OTC: CSRH), through its Universal Mobile Interface™ (“UMI”) solution, delivers and manages complex, digitally secure transactions servicing a broad range of vertical markets in the fintech space. To view the full article, visit:

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.003, off by 1.32%, on 1,618,444 volume with 31 trades. The average volume for the last 60 days is 11,181,395 and the stock's 52-week low/high is $0.0005/$0.0085.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company" or "Choom™") applauds the passing of Bill C-45 by the Canadian Senate, paving the way for official legalization of recreational use cannabis in Canada. After today's important vote, we see blue skies ahead- with a hint of green. Also today, CannabisNewsWire released a report on the company detailing how CHOOF morning commended the passing of Bill C-45 by the Canadian Senate. To view the full press release, visit:

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.70, up 2.96%, on 328,038 volume with 206 trades. The average volume for the last 60 days is 211,124 and the stock's 52-week low/high is $0.18/$0.8612.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile (TSX.V: LITH) (OTC: LTMCF) is utilizing its vast land package and experienced management team to advance as a company while assisting North American battery makers in their efforts to stay competitive despite the production capacity of China’s battery manufacturers. To view the full article, visit:

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.77, up 0.31%, on 76,158 volume with 58 trades. The average volume for the last 60 days is 7,321 and the stock's 52-week low/high is $0.001/$0.9021.

Recent News


Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF) ("Sunniva" or the “Company”), a North American provider of cannabis products and services, is pleased to announce that its wholly-owned subsidiary CP Logistics, LLC (the “Sun-Oil Facility”) has secured an extraction contract with Farmacy Phactory, a leading California cannabis brand.

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $6.1988, up 0.19%, on 50,680 volume with 141 trades. The average volume for the last 60 days is 34,644 and the stock's 52-week low/high is $0.001/$16.00.

Recent News



The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF).

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) is eyeing wide opportunity in the multi-billion legal sports betting market with the recent U.S. Supreme Court’s landmark decision to open the door for states to regulate legalization of sports gambling. To view the full article, visit:

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric “argument engine” measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards.

Building on the company’s tag line – “Pick a Fight” – the FANDOM SPORTS app provides an always fresh, authentic rush of deeper-than-surface interactive content that resonates with the targeted age demographic of 18-34. Intense sports fans aren’t afraid of stepping up to the plate to engage other users by unleashing their opinions within the app’s structured debate resolution tool coined “FanFights.” Sports-loving fans can explore, gloat, vote, invite friends, create provocative FanFight topics and play to win while inside the FANDOM SPORTS app, which is currently available in the Apple App store and coming to the Google Play store imminently. The company’s self-learning algorithm predicts and collects user preferences while building relevant personalized FanFight channels, bringing the concept of competitive, in-your-face conversation to a whole new level of sports entertainment.

The FANDOM SPORTS app is free to play (F2P) with in-app purchase and subscription capabilities. The gaming aspect of the ecosystem is built on behavioral economics and delivers multiple revenue streams by maximizing average revenue per daily active user (ARPDAU) and user-generated content (UGC), with select placement of high-impact video and moment-based marketing as part of the brand-sponsored FanFights and in-app offers. The global platform enables applications (either FANDOM SPORTS created or 3rd party apps) to be operated in partnership with leading sports themed brands, leagues, and service providing companies within three verticals – live action, eSports, & fantasy – from around the world by supplying “interactive sports entertainment” to fans. The FANDOM SPORTS platform creates a bullet-proof snapshot of the app’s fan base through a Blockchain supported “PlayerCard” in tandem with the “Engagement Score”, which doubles as an invaluable acquisition and retention tool for its business operators. FANDOM SPORTS hosted transactions are placed on the distributed ledger, making them immutable and public to verified users interacting within the business ecosystem. Tracking this digital footprint provides extremely valuable metadata generated by users’ very dynamic behavior and sports passion.

FANDOM SPORTS’ Brand and Sponsorship partners are harnessing the affluent sports fans age 18-34 with integrated marketing content and service experience. The moments-based marketing integration will translate through FanCoin redemption, in exchange for items provided by programs established by FANDOM SPORTS and its clients. These programs are a key part of the business model and covers, as an example, the following partners; Sports Leagues, TelCo’s service offerings, and Content owners (i.e. FANDOM SPORTS provides new paying customers to the owners of pay-per-view platforms).

“Pick A Fight. Talk Trash. Get Rewarded.”

FANDOM SPORTS Media is an entertainment company that aggregates, curates and produces unique fan-focused content.

The FANDOM SPORTS App is the Company’s core product, which is the ultimate destination for unfiltered raw sports talk. The app allows passionate sports fans to unleash their primal sports passions, pick fights and earn rewards.

So download the app and bring your crew. Talking trash is better with friends. The more you invite, the more FanCoins you earn.

You may also visit the Company’s website at or contact them directly at


The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond the Company’s control. Some of these risks and uncertainties may be described in the Company’s corporate filings (posted at

The Company has no intention or obligation to update or revise any forward-looking statements due to new information or events

FANDOM SPORTS Media Corp. (FDMSF), closed the day's trading session at $0.08331, even for the day. The average volume for the last 60 days is 8,915 and the stock's 52-week low/high is $0.001/$0.3911.

Recent News


Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF).

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) has a lot to gain if the 2018 Farm Bill, which the U.S. Senate is currently debating, passes. To view the full article, visit: Also today, CannabisNewsWire released a report on the company detailing how GBHPF, together with Marijuana Company of America (OTC: MCOA), Global Hemp is already executing its plan to cultivate hemp on a commercial basis in North America, with operations in New Brunswick, Canada, and Oregon.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTCQB: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries with the commitment to improve quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp.

The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) ( in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry.

Global Hemp Group has chosen to only work with suppliers of high quality, sustainable raw materials and finished products derived from the hemp plant. Among the leading industries utilizing industrial hemp’s exceptional properties is the automotive sector, building materials market, bio-composites, energy-related markets, super-foods, nutritional supplements, nutraceuticals and the cannabinoid markets. Guided by the principal theme of “global environmental stewardship,” Global Hemp Group focuses on the key concepts of sustainability and social responsibility in all its endeavors.

Global Hemp Group’s joint venture with publicly traded Marijuana Company of America on hemp cultivation trials in 2017, designed to develop commercial hemp production on the Acadian peninsula of New Brunswick, Canada, for the first time in 20 years, was a great success. The partners are preparing for the upcoming changes in Canada’s cannabis legislation that will permit cannabinoid extraction from industrial hemp. Farmers have already been recruited to plant a minimum of 125 acres of industrial hemp for the 2018 growing season, with the goal of increasing the acreage under cultivation to 1,000+ acres by year three of the joint project. Global Hemp Group is preparing an application for a processing license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials for the upcoming harvest in October 2018, with a longer term plan to establish permanent processing facilities by October 2019.

Global Hemp Group is led by Charles Larsen as its president, CEO and chairman of the board. Larsen’s more than 30 years of experience working in government, public, private and startup companies as an executive manager includes being the founding president of Medical Marijuana, Inc., the first public company in the Cannabis space. Larsen is also a founder and current director of Marijuana Company of America, Inc., and has been actively involved in the cannabis and hemp industry for nearly a decade. Larsen is joined by Curt Huber, who serves as CFO and director. Huber is an independent corporate and financial consultant with more than 25 years of experience in all facets of public companies among many different sectors including mining, oil and gas, and technology.

Also joining the management team as director is Dr. Paul T. Perrault, an agricultural economist trained in cooperative development and in rural development. Perrault’s experience includes years of consulting on rural development projects introducing new crops in several developing countries and strengthening agricultural research organizations, principally in Africa. Jeff Kilpatrick also serves as a director and is currently a program supervisor of Alachua County Department of Court Services in Gainesville, Florida. Kilpatrick, who spent 21 years in the U.S. Coast Guard, is a member of LEAP – Law Enforcement Against Prohibition – and is president elect for the National Association of Pretrial Services Agencies (NAPSA).

Global Hemp Group’s business philosophy is “A healthier future through sustainable business strategies.“

Global Hemp Group, Inc. (GBHPF), closed the day's trading session at $0.1439, off by 0.07%, on 182,866 volume with 56 trades. The average volume for the last 60 days is 182,655 and the stock's 52-week low/high is $0.0115/$0.316.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Hemp advocates at Marijuana Company of America, Inc. (OTC: MCOA) are advancing cultivation projects that will give the company a significant supply of non-intoxicating cannabidiol (CBD) for market under the hempSMART and BeniHemp brands. Also today, CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America, a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name “hempSMART™”; an affiliate marketing program to promote and sell its products; leasing of real property to business entities engaged in the growth and sale of cannabis; and expansion of its business into ancillary areas of the legalized cannabis and hemp industry.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.047, off by 2.69%, on 9,968,899 volume with 480 trades. The average volume for the last 60 days is 5,506,638 and the stock's 52-week low/high is $0.0188/$0.0728.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint President Wil Ralston provides an update of recent company activities. To view the full interview, visit: To view the full press release, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.036, off by 8.63%, on 6,170,591 volume with 369 trades. The average volume for the last 60 days is 8,951,444 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.